by EmpathiCSubstanceS | Nov 24, 2019 | Alcoholism
Supplementing psychotherapy with small doses of MDMA could be an effective strategy to prevent relapses of alcohol addiction in patients, an ongoing small clinical trial suggests. The research is yet another example of how scientists and doctors are finding or...
by EmpathiCSubstanceS | Nov 24, 2019 | Addiction
Scientists from the Johns Hopkins Psychedelic Research Unit are commencing a landmark human clinical trial to explore the effects of psilocybin in persons with chronic anorexia nervosa (AN). The new trial adds to a growing body of evidence finding psychedelic...
by EmpathiCSubstanceS | Nov 24, 2019 | Anxiety
Scientists from the Johns Hopkins Psychedelic Research Unit are commencing a landmark human clinical trial to explore the effects of psilocybin in persons with chronic anorexia nervosa (AN). The new trial adds to a growing body of evidence finding psychedelic...
by EmpathiCSubstanceS | Nov 24, 2019 | Addiction
The heavy hallucinogen ibogaine is illegal in the US, but some addicts are flocking to Mexican clinics for it, hoping to be cured. A physician investigates. ILLUSTRATION: YUKAI DU I’m not sure I’ve ever met an opioid user who didn’t want to quit, and as an emergency...
by EmpathiCSubstanceS | Sep 9, 2019 | Anxiety
The research center, with $17 million from donors, aims to give “psychedelic medicine” a long-sought foothold in the scientific establishment. Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely...
